| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Passage Bio (NASDAQ:PASG) reported its Q3 earnings results on Monday, November 13, 2023 at 07:00 AM.
Here's what investors need to know about the announcement.
Passage Bio missed estimated earnings by 6.52%, reporting an EPS of $-0.49 versus an estimate of $-0.46.
Revenue was down $0 from the same period last year.
Last quarter the company beat on EPS by $0.04 which was followed by a 2.04% increase in the share price the next day.
To track all earnings releases for Passage Bio visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: PASG
